Lexaria Bioscience (LEXX) Capital Expenditures (2010 - 2026)
Lexaria Bioscience's Capital Expenditures was $40,816 in fiscal Q2 2026 (quarter ended Feb 28, 2026), compared with $1.00 a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Capital Expenditures (2010 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Capital Expenditures at Lexaria Bioscience came in at $24,646, down 42.7% from FY2024.
- Capital Expenditures shows a three-year compound annual growth rate of -20.6% (FY2022 to FY2025).
- In earlier fiscal years, Capital Expenditures was $43,014 in FY2024 (+27.5%), $33,748 in FY2023 (-31.4%) and $49,192 in FY2022.
- The fiscal Q2 2026 figure marks the highest quarterly Capital Expenditures since fiscal Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Lexaria Bioscience | 3.26 Mn | -12.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2026 | 40,816.00 |
| Aug 31, 2025 | 1.00 |
| May 31, 2025 | -1.00 |
| Feb 28, 2025 | 1.00 |
| Nov 30, 2024 | 24,645.00 |
| Aug 31, 2024 | 43,014.00 |
| Feb 28, 2023 | 13,248.00 |
| Nov 30, 2022 | 20,500.00 |
| Aug 31, 2022 | 4.00 |
| May 31, 2022 | 6,813.00 |
| Nov 30, 2021 | 42,375.00 |
| Feb 28, 2021 | -273,375.00 |
| Aug 31, 2019 | 9,522.00 |
| May 31, 2019 | 195,511.00 |
| Feb 28, 2019 | 318,318.00 |
| Nov 30, 2018 | 122,832.00 |
| May 31, 2016 | 309.00 |
| Feb 29, 2016 | -309.00 |
| Nov 30, 2015 | 3,094.00 |
| Jul 31, 2014 | 123,956.00 |
API Access
Lexaria Bioscience Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();